Sinopharm Group Co. Ltd.
SHTDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $54 | $64 | $55 | $44 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $207 | $186 | $171 | $173 |
| Inventory | $62 | $60 | $61 | $51 |
| Other Curr. Assets | $14 | $16 | $17 | $13 |
| Total Curr. Assets | $347 | $337 | $319 | $291 |
| Property Plant & Equip (Net) | $20 | $20 | $18 | $18 |
| Goodwill | $6 | $7 | $7 | $7 |
| Intangibles | $5 | $3 | $5 | $5 |
| Long-Term Investments | $11 | $11 | $10 | $9 |
| Tax Assets | $2 | $0 | $2 | $2 |
| Other NC Assets | $1 | $6 | $4 | $4 |
| Total NC Assets | $45 | $47 | $45 | $44 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $393 | $383 | $365 | $335 |
| Liabilities | – | – | – | – |
| Payables | $157 | $155 | $145 | $133 |
| Short-Term Debt | $63 | $55 | $53 | $55 |
| Tax Payable | $0 | $3 | $3 | $3 |
| Deferred Revenue | $0 | $0 | $0 | $22 |
| Other Curr. Liab. | $17 | $18 | $22 | -$4 |
| Total Curr. Liab. | $250 | $241 | $235 | $219 |
| LT Debt | $9 | $14 | $12 | $8 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $1 | $1 | $1 |
| Other NC Liab. | $4 | $3 | $3 | $3 |
| Total NC Liab. | $16 | $22 | $20 | $16 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $5 | $5 | $5 |
| Total Liabilities | $266 | $263 | $255 | $236 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $4 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | $54 | $49 | $43 | $39 |
| AOCI | $22 | $0 | -$4 | -$4 |
| Other Equity | $0 | $22 | $2 | $0 |
| Total Equity | $79 | $75 | $68 | $62 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $48 | $46 | $42 | $38 |
| Total Liab. & Tot. Equity | $393 | $383 | $365 | $335 |
| Net Debt | $17 | $5 | $10 | $20 |